Although there are some differences in the expression of these indicators of angiogenesis in HAE lesions and peripheral infiltration of the liver tissue, these findings provide a new direction for the application of VEGF signaling pathway-targeted drugs in the treatment of HAE to a certain extent. The gene discussed is VEGFA; the disease is hereditary angioedema.